Revance · 1 month ago
Clinical Affairs Intern 2026
United States
Internship
Remote
Intern
Start in 2026Revance is a global company developing, producing, and distributing industry-leading, differentiated products across aesthetics, skincare, and therapeutics. The Clinical Affairs Intern will support clinical research and operational activities within the clinic environment, providing hands-on exposure to clinical study conduct, patient engagement, and data collection.
BiotechnologyHealthcarePharmaceuticalHealth CareTherapeutics
Responsibilities
Support clinic-based clinical research activities and study execution
Assist with patient scheduling, visit preparation, and study logistics
Help collect, organize, and maintain study documentation and clinical records
Assist with data entry, quality checks, and tracking of study-related information
Observe and support patient visits and clinical procedures in accordance with study protocols
Maintain research files and ensure documentation is complete and organized
Participate in team meetings and assist with administrative and operational projects
Adhere to applicable privacy, compliance, and regulatory requirements
Qualification
Required
Currently pursuing a Bachelor's or Master's degree in Life Sciences, Health Sciences, Nursing, Public Health, or a related field
Strong organizational skills and attention to detail
Excellent communication and interpersonal skills
Ability to maintain confidentiality and professionalism in a patient-care environment
Proficiency with Microsoft Office applications
Preferred
Interest in clinical research, healthcare, medical aesthetics, or patient care
Prior experience in a healthcare, clinic, laboratory, or research setting
Company
Revance
We believe that science-powered innovation creates possibilities.
Founded in 2002
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.68BKey Investors
Athyrium Capital Management LP"CNF Investments, LLC",Essex Woodlands Healthcare Partners,Novaquest Capital ManagementEssex Woodlands Healthcare Partners
2024-08-12Acquired
2024-03-04Post Ipo Equity· $100M
2022-09-12Post Ipo Equity· $200M
Leadership Team
Nadeem Moiz
Chief Executive Officer
Steve Kreider
Executive Vice President, Chief Revenue Officer - Aesthetics and Therapeutics
Recent News
2026-06-01
Company data provided by crunchbase